News Posts List
30 Simple Ways You Can Prevent Cancer
07/27/2018
People who eat broccoli and its cousins such as cabbage, cauliflower and bok choy at least once per week have a lower risk of kidney cancer compared with people who consume them less than once a month, according to a multinational European study.
Combined assessment of low PGRMC1/positive ATP1A1 levels has enhanced prognostic value for renal cell carcinoma
07/27/2018
Progesterone receptor membrane component 1 (PGRMC1) and Na+/K+‑ATPase α1 subunit (ATP1A1) are two proteins associated with the clinical prognosis of renal cell carcinoma (RCC) and RCC cell proliferation. However, the two proteins have been previously studied independently, and their combined influence on the clinical outcome of RCC remains unclear.
Choueiri Reflects on Recent RCC Advances
07/27/2018
Toni K. Choueiri, MD reflects on recent RCC advances.
Patients With Early Kidney Cancer Benefit From Robotic Partial Nephrectomy
07/26/2018
A comprehensive study by the Keck School of Medicine of USC, which has found that robotic partial nephrectomy offers significantly better patient outcomes.
mRCC: Cytoreductive Nephrectomy in the Modern Era
07/26/2018
Walter Stadler, M.D., who is on our medical steering committee, is one of the panelists in this video.
Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma
07/25/2018
Clear cell renal cell carcinoma (ccRCC) is the main subtype of malignant kidney cancer. Long non‑coding RNA (lncRNA) serves a key role in predicting survival in patients with cancer.
Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis
07/25/2018
Treatment of patients with metastatic renal cell carcinoma (mRCC) and end-stage renal disease (ESRD) on dialysis poses a therapeutic challenge, particularly as this patient group was excluded from the pivotal clinical trials. In addition, there is uncertainty regarding drug dosing/pharmacokinetics, lack of safety and efficacy data, and potential for increased toxicity when using targeted therapy or immunotherapy for the management of patients with mRCC on dialysis.
Good results seen with laparoscopic partial nephrectomy following selective embolization of tumor
07/25/2018
The short-term oncological and functional outcomes for partial nephrectomy are comparable for laparoscopic partial nephrectomy following selective embolization of tumor (LPNE) in a hybrid operating room and robot-assisted partial nephrectomy (RAPN). A longer follow-up and a larger cohort of patients would be necessary to verify the benefits of LPNE, which appears to be a very interesting alternative to RAPN.
Poorer RCC outcomes with incidental upstaging after partial nephrectomy
07/25/2018
Patients with incidental pathologic T3a (pT3a) upstaging after partial nephrectomy (PN) have significantly reduced recurrence-free survival (RFS) and cancer-specific survival (CSS) when compared to patients whose disease isn't upstages from pT1a-b.
Rise in Localized High-Risk RCC Reported
07/24/2018
Over a 25-year period, the proportion of patients with high-risk clinical T1 tumors increased by nearly 20 percent and clinical tumor size decreased from 8.4 to 6.2 cm, an Italian study found.
News Feed